Risk factor
Good trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Target Price
The average target price of PRVA is 30 and suggests 36% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell